Head to Head Stocks: Sorrento Therapeutics, Inc. (NASDAQ:SRNE), Aegon NV (NYSE:AEG)

earning reaction history, nasdaq, nyse

Sorrento Therapeutics, Inc. (NASDAQ:SRNE)

Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $4.06 on the last trading session with an decrease of -0.25%, whereas, it previously closed at $4.07. The company has a market capitalization of $489.55 Million. The company traded shares of 1.01 Million on the trading day while its three month average volume stands at 2.95 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) produced diluted EPS of -1.93. The EPS estimate for next year as estimated by analysts is at -0.73 while EPS for next quarter is estimated at -0.34. Earnings per Share growth for this year is reported at 33.3, while the analysts estimated the EPS growth for next year at -0.73% and Earnings growth for next 5 years stands at 37% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -5.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) stands at 23.09 and Price to Book or P/B for the most recent quarter stands at 2.36. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) are reported at 2.9 and 2.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Sorrento Therapeutics, Inc. (NASDAQ:SRNE) stands at -38.7, -88.5 and -34.4 respectively

The trailing twelve month Revenue of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is reported at 21.2 Million with income of -203500000. The outstanding shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) are 120.58 Million. The institutional Ownership of the shares of 25.9 stands at 0.80%, this figure is decreased -0.03 in the last six months. The insider ownership for the shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is ticked at 29.37%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is the Mean Target Price estimated by the analysts which stands at 20.67. The 52 week high of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) is placed at 8.25 and 52 week low is standing at 1.80.

Performance wise the shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) fell down -0.73% for the week, it also rise 47.64% for the monthly performance, while for the quarter it went down 78.85%. The shares increase 13.09% for the half year and flew up for the Year-To-Date performance. The shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) shrinked -37.54% for the yearly performance.

Aegon NV (NYSE:AEG)

Aegon NV (NYSE:AEG) closed at $5.18 on the last trading session with an increase of 1.77%, whereas, it previously closed at $5.09. The company has a market capitalization of $11.01 Billion. The company traded shares of 1.44 Million on the trading day while its three month average volume stands at 1.88 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Aegon NV (NYSE:AEG) produced diluted EPS of 0.35. The EPS estimate for next year as estimated by analysts is at 0.83 while EPS for next quarter is estimated at 0. Earnings per Share growth for this year is reported at -71.6, while the analysts estimated the EPS growth for next year at 0.83% and Earnings growth for next 5 years stands at -11.6% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Aegon NV (NYSE:AEG) is at 14.97 while the forward p/e is at 6.24. The P/S or Price to Sales ratio of Aegon NV (NYSE:AEG) stands at 0.48 and Price to Book or P/B for the most recent quarter stands at 0.41. The Price to Free Cash Flow ratio or P/FCF is reported at 90.81. The quick ratio and the current ratio of Aegon NV (NYSE:AEG) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Aegon NV (NYSE:AEG) stands at 0.2, 2.7 and 1.4 respectively

The trailing twelve month Revenue of Aegon NV (NYSE:AEG) is reported at 23.07 Billion with income of 708 Million. The outstanding shares of Aegon NV (NYSE:AEG) are 2.12 Billion. The institutional Ownership of the shares of 8.2 stands at 0.80%, this figure is decreased -0.03 in the last six months. The insider ownership for the shares of Aegon NV (NYSE:AEG) is ticked at 10.1%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Aegon NV (NYSE:AEG) is the Mean Target Price estimated by the analysts which stands at 6.02. The 52 week high of Aegon NV (NYSE:AEG) is placed at 7.48 and 52 week low is standing at 4.42.

Performance wise the shares of Aegon NV (NYSE:AEG) rose up 4.65% for the week, it also fell -3.72% for the monthly performance, while for the quarter it went down 4.23%. The shares decrease -15.5% for the half year and flew up for the Year-To-Date performance. The shares of Aegon NV (NYSE:AEG) shrinked -28.16% for the yearly performance.